Showing results (71-80 of 189) with videos related to

Sort By:
Pageof 19
Pediatrics|April 3, 2003
Predictors of low back pain in British schoolchildren: a population-based prospective cohort studyGareth T Jones, Kath D Watson, Alan J Silman, et al.
The Journal of Rheumatology|December 17, 2003
Development of resource-use and expenditure questionnaires for use in rheumatology researchNicola J Cooper, Miranda Mugford, Deborah P M Symmons, et al.
Annals of the Rheumatic Diseases|October 15, 2011
Multiple adverse pregnancy outcomes before symptom onset are associated with a worse disease outcome in women with recent-onset inflammatory polyarthritisE M Camacho, S M M Verstappen, M Lunt, et al.
Arthritis Care & Research|December 1, 2011
Influence of age and sex on functional outcome over time in a cohort of patients with recent-onset inflammatory polyarthritis: results from the Norfolk Arthritis RegisterElizabeth M Camacho, Suzanne M M Verstappen, Mark Lunt, et al.
Annals of the Rheumatic Diseases|February 23, 2008
Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis?S L Hider, A J Silman, W Thomson, et al.
American Journal of Epidemiology|January 21, 2009
Different methods of balancing covariates leading to different effect estimates in the presence of effect modificationMark Lunt, Daniel Solomon, Kenneth Rothman, et al.
The Journal of Rheumatology|February 8, 2006
Developing classification criteria for peripheral joint psoriatic arthritis. Step I. Establishing whether the rheumatologist's opinion on the diagnosis can be used as the "gold standard"Deborah P M Symmons, Mark Lunt, Gillian Watkins, et al.
Annals of the Rheumatic Diseases|July 26, 2011
Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics RegisterRebecca Davies, James B Galloway, Kath D Watson, et al.
Annals of the Rheumatic Diseases|May 10, 2011
In patients with early inflammatory polyarthritis, ACPA positivity, younger age and inefficacy of the first non-biological DMARD are predictors for receiving biological therapy: results from the Norfolk Arthritis RegisterSuzanne M M Verstappen, Mark Lunt, Diane K Bunn, et al.
RMD Open|September 29, 2017
Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologicKatie L Druce, Kundan Iqbal, Kath D Watson, et al.
Pageof 19